{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-012945","form_type":"8-K","ticker":"AIFF","cik":"0000803578","company_name":"FIREFLY NEUROSCIENCE, INC.","filed_at":"2025-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.335178+00:00","generated_at":"2026-05-23T07:38:09.677203+00:00","sec_items":["5.02","1.01","3.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Firefly Neuroscience names David DeCaprio President & COO; settles McLean dispute, issues shares to warrant holders","bullets":["David DeCaprio appointed President and COO effective April 18, 2025; receives $250k base salary, bonus up to 50%, and RSU award of 263,952 shares.","Settlement with Ian McLean resolves Ontario litigation; Firefly issues 21,000 common shares to 1128526 Alberta Ltd. under private placement.","Firefly issues 122,407 shares to BPY Limited and 217,593 shares to Nomis Bay Ltd. as inducement for prior warrant exercise.","CEO Greg Lipschitz granted 395,927 RSUs under 2024 LTIP; half vest monthly over 3 years, half tied to performance targets.","Arun Menawat appointed to board committees replacing DeCaprio: Compensation (chair), Audit, Nominating and Governance."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-012945","json":"https://secwatch.observer/filing/0001437749-25-012945.json","markdown":"https://secwatch.observer/filing/0001437749-25-012945.md","text":"https://secwatch.observer/filing/0001437749-25-012945.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/803578/000143774925012945/0001437749-25-012945-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/803578/000143774925012945/wavd20250424_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T07:38:09.677203+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4ab947fd69","claim":"David DeCaprio was appointed as President and Chief Operating Officer at FIREFLY NEUROSCIENCE, INC..","evidence_excerpt":"On April 18, 2025, the Board of Directors (the “Board”) of Firefly Neuroscience, Inc. (the “Company”) appointed David DeCaprio (“DeCaprio”) as the President and Chief Operating Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/803578/000143774925012945/0001437749-25-012945-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}